KA
LLY icon

Kintegral Advisory’s Eli Lilly LLY Stock Holding History

Kintegral Advisory’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14M Sell
15,208
-674
-4% -$683K 1.33% 10
2025
Q4 		$17.1M Sell
15,882
-435
-3% -$416K 1.45% 7
2025
Q3 		$12.4M Sell
16,317
-73
-0.4% -$54.3K 1.06% 18
2025
Q2 		$12.8M Sell
16,390
-25
-0.2% -$19.4K 1.16% 15
2025
Q1 		$13.6M Sell
16,415
-56
-0.3% -$46.6K 1.37% 9
2024
Q4 		$12.7M Sell
16,471
-768
-4% -$636K 1.2% 11
2024
Q3 		$15.3M Sell
17,239
-226
-1% -$203K 1.4% 6
2024
Q2 		$15.8M Buy
17,465
+1,570
+10% +$1.26M 1.52% 7
2024
Q1 		$12.4M Sell
15,895
-50
-0.3% -$35.6K 1.24% 12
2023
Q4 		$9.29M Sell
15,945
-102
-0.6% -$59.5K 1.03% 17
2023
Q3 		$8.62M Sell
16,047
-10
-0.1% -$5.15K 1.06% 16
2023
Q2 		$7.53M Hold
16,057
– – 0.89% 22
2023
Q1 		$5.51M Sell
16,057
-863
-5% -$291K 0.71% 36
2022
Q4 		$6.19M Buy
16,920
+5,900
+54% +$2.09M 0.82% 31
2022
Q3 		$3.56M Hold
11,020
– – 0.49% 52
2022
Q2 		$3.57M Buy
11,020
+233
+2% +$69.9K 0.46% 55
2022
Q1 		$3.09M Buy
10,787
+241
+2% +$62K 0.34% 77
2021
Q4 		$2.91M Hold
10,546
– – 0.3% 84
2021
Q3 		$2.44M Hold
10,546
– – 0.29% 83
2021
Q2 		$2.42M Hold
10,546
– – 0.29% 85
2021
Q1 		$1.97M Hold
10,546
– – 0.25% 99
2020
Q4 		$1.78M Hold
10,546
– – 0.24% 103
2020
Q3 		$1.56M Sell
10,546
-339
-3% -$52.5K 0.24% 103
2020
Q2 		$1.79M Hold
10,885
– – 0.29% 84
2020
Q1 		$1.51M Buy
10,885
+1,218
+13% +$167K 0.29% 88
2019
Q4 		$1.27M Hold
9,667
– – 0.23% 115
2019
Q3 		$1.08M Hold
9,667
– – 0.22% 126
2019
Q2 		$1.07M Hold
9,667
– – 0.22% 123
2019
Q1 		$1.25M Sell
9,667
-409
-4% -$49.7K 0.26% 108
2018
Q4 		$1.17M Buy
+10,076
New +$1.13M 0.35% 74

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Kintegral Advisory's LLY Position: Q1 2026 in Review

Kintegral Advisory reduced its Eli Lilly (LLY) stake by 4.2% in Q1 2026, selling an estimated $683K and leaving 15,208 shares worth $14M. The position accounts for 1.33% of the portfolio, ranked #10.

Kintegral Advisory first reported a position in LLY in Q4 2018 and has held it in 30 quarters since. The position peaked at $17.1M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Kintegral Advisory held 15,208 shares of Eli Lilly worth $14M as of Q1 2026.
  • Kintegral Advisory sold 674 Eli Lilly shares in Q1 2026, an estimated $683K.
  • Eli Lilly made up 1.33% of Kintegral Advisory's portfolio in Q1 2026, its #10 holding.
  • Kintegral Advisory first reported a position in Eli Lilly in Q4 2018 and has held it in 30 quarters since.
  • Kintegral Advisory's Eli Lilly position peaked at $17.1M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Kintegral Advisory's 13F filing for Q1 2026, filed 14 May 2026.